Journal of Nanobiotechnology | |
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging | |
Research | |
Khalid M. Abu-Salah1  Fei Ye2  Ibrahim El-Serafi2  Manuchehr Abedi-Valugerdi2  Ramy El-Sayed2  Åsa Barrefelt2  Moustapha Hassan3  Ying Zhao3  Mamoun Muhammed4  Heba Asem5  Jörg Hamm6  | |
[1] Department of Nanomedicine, King Abdullah International Medical Research Center, King Abdulaziz Medical City, PO Box 22490, 11426, Riyadh, Saudi Arabia;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;Clinical Research Center (KFC), Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden;Division of Functional Materials (FNM), Department of Materials and Nanophysics, Royal Institute of Technology (KTH), 164 40, Stockholm, Sweden;Division of Functional Materials (FNM), Department of Materials and Nanophysics, Royal Institute of Technology (KTH), 164 40, Stockholm, Sweden;Division of Experimental Cancer Medicine (ECM), Department of Laboratory Medicine (LABMED), Karolinska Institutet (KI), 141 86, Stockholm, Sweden;PerkinElmer, 68 Elm St., 01748, Hopkinton, MA, USA; | |
关键词: Biodegradable polymer; Drug delivery; Magnetic resonance imaging; In vivo fluorescence imaging; Biodistribution; Busulphan; Cancer; | |
DOI : 10.1186/s12951-016-0239-0 | |
received in 2016-10-06, accepted in 2016-12-03, 发布年份 2016 | |
来源: Springer | |
【 摘 要 】
BackgroundMultifunctional nanocarriers for controlled drug delivery, imaging of disease development and follow-up of treatment efficacy are promising novel tools for disease diagnosis and treatment. In the current investigation, we present a multifunctional theranostic nanocarrier system for anticancer drug delivery and molecular imaging. Superparamagnetic iron oxide nanoparticles (SPIONs) as an MRI contrast agent and busulphan as a model for lipophilic antineoplastic drugs were encapsulated into poly (ethylene glycol)-co-poly (caprolactone) (PEG-PCL) micelles via the emulsion-evaporation method, and PEG-PCL was labelled with VivoTag 680XL fluorochrome for in vivo fluorescence imaging.ResultsBusulphan entrapment efficiency was 83% while the drug release showed a sustained pattern over 10 h. SPION loaded-PEG-PCL micelles showed contrast enhancement in T2*-weighted MRI with high r2* relaxivity. In vitro cellular uptake of PEG-PCL micelles labeled with fluorescein in J774A cells was found to be time-dependent. The maximum uptake was observed after 24 h of incubation. The biodistribution of PEG-PCL micelles functionalized with VivoTag 680XL was investigated in Balb/c mice over 48 h using in vivo fluorescence imaging. The results of real-time live imaging were then confirmed by ex vivo organ imaging and histological examination. Generally, PEG-PCL micelles were highly distributed into the lungs during the first 4 h post intravenous administration, then redistributed and accumulated in liver and spleen until 48 h post administration. No pathological impairment was found in the major organs studied.ConclusionsThus, with loaded contrast agent and conjugated fluorochrome, PEG-PCL micelles as biodegradable and biocompatible nanocarriers are efficient multimodal imaging agents, offering high drug loading capacity, and sustained drug release. These might offer high treatment efficacy and real-time tracking of the drug delivery system in vivo, which is crucial for designing of an efficient drug delivery system.
【 授权许可】
CC BY
© The Author(s) 2016
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202311108185823ZK.pdf | 6517KB | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]